Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambisome and Miltefosine for VL in HIV Co-infected Patients
NCT02011958Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miltefosine in visceral leishmaniasis (VL), sponsored by Drugs for Neglected Diseases initiative. Started Jul 2014; status: completed.
02
Drugs
miltefosine
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT02011958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011958.